throbber

`
`
`
`
`
`
`
`
`
`
`
`
`
`LAWYERS' AND MERCHANTS' TRANSLATION BUREAU, INC.
`
`Legal, Financial, Scientific, Technical and Patent Translations
`
`30 BROAD STREET, 41ST FLOOR
`
`NEW YORK, NY 10004
`
`Certificate of Accuracy
`
`TRANSLATION
`
`From German into English
`
`
`Date: August 22, 2017
`
`
`
`I, Charles Edward Sitch, BA, declare
`
`
`
`That to the best of my knowledge and belief, the attached document, prepared by one
`of its translators competent in the art and conversant with the German and English languages,
`is a true, correct and accurate translation into the English language of the accompanying
`document.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Vice President
`
`LAWYERS' AND MERCHANTS'
`TRANSLATION BUREAU
`
`1
`
`ELIX 1004
`
`

`

`Isothermal In Vitro Selection and
`Amplification to Investigate
`Evolutionary Processes
`
`
`
`
`
`
`Dissertation
`to obtain the Doctor of Philosophy degree
`from the Faculty of Chemistry
`at Ruhr-University Bochum
`
`
`
`
`submitted by
`Sylvia Ehses
`from Bernkastel-Kues
`
`Sankt Augustin 2005
`
`
`
`
`
`
`
`
`
`2
`
`

`

`This work was prepared between October 2002 and January 2005 under the supervision of Prof.
`Dr. G. von Kiedrowski and between February 2005 and April 2005 under the supervision of Prof.
`Dr. J. S. McCaskill at the Fraunhofer Society e.V. in Sankt Augustin.
`
`Parts of this work have been published: S. Ehses, J. Ackermann, J. S. McCaskill: Optimization and
`Design of oligonucleotide setup for Strand Displacement Amplification. Journal of Biochemical
`and Biophysical Methods, 63(3): 170 – 86, 2005.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1st Principal Investigator: Prof. Dr. J. S. McCaskill
`2nd Principal Investigator: Prof. Dr. G. von Kiedrowski
`Third examiner: Prof. Dr. W. Schuhmann
`Date of the oral examination: 07.08.2005
`
`
`
`
`
`
`
`3
`
`

`

`
`
`
`
`
`
`
`
`
`
`Abstract
`The development of a system is presented here that uses simple in vitro biochemical systems to
`investigate evolutionary processes. As a biochemical reaction, SDA (strand displacement
`amplification) was developed further as a DNA amplification mechanism and was adapted to meet
`the requirements of an in vitro evolution experiment. In addition to a SELEX setup based on the
`mutation and selection of nucleic acids, the system was adapted with regard to developing a self-
`contained evolvable system. Thus, it was demonstrated how the amplification mechanism can be
`controlled in microfluidic structures - a step toward complex systems that will help answer
`fundamental questions about evolution.
`
`
`
`
`
`
`
`
`
`4
`
`

`

` I
`
` would like to take this opportunity to thank all those who accompanied me throughout the time
`this work came into being.
`
`Firstly, I owe a debt of gratitude to Prof. Dr. John S. McCaskill under whose supervision I learned
`to grasp and process the subject matter concerned.
`
` I
`
` am grateful to the Fraunhofer Society for the financial and material support that enabled me to
`drive this work forward under excellent working conditions.
`
`My thanks also go to Prof. Dr. G. von Kiedrowski who, in addition to substantive discussions, also
`provided organizational assistance.
`
`Despite the structural changes and the, at times, difficult working conditions, I would like to thank
`the individual members of the former BioMIP research group for their constant willingness to help
`and their personable company.
`
` I
`
` would like to thank my parents for their tireless support throughout these years. Also, I thank
`Stefan whose companionship and patience over many years made many things easier. Moreover, I
`am grateful to Robert for his sometimes sobering, but also motivating, words.
`
`It would be amiss of me not to also thank those who encouraged me by simply believing that this
`project was finite…
`
`
`
`
`
`5
`
`

`

`1.2 
`
`Table of contents
`1 
`Introduction ................................................................................................... 13 
`1.1  Molecular evolution ............................................................................ 14 
`In vitro selection and SELEX .................................................. 14 
`1.1.1 
`1.1.2  Molecular fitness landscapes ................................................... 15 
`Isothermal amplification procedures .................................................. 16 
`1.2.1  Strand displacement amplification .......................................... 17 
`Contents of the work ........................................................................... 20 
`1.3 
`2  Materials and methods ................................................................................. 23 
`2.1  Materials ............................................................................................. 23 
`2.1.1  Chemicals, enzymes, standards ............................................... 23 
`2.1.2  Apparatus ................................................................................ 25 
`2.1.3  Software .................................................................................. 26 
`2.1.4  Oligonucleotides, plasmids and bacterial strains .................... 26 
`2.1.5  Overview of oligonucleotides ................................................. 26 
`2.1.6  Bacterial strains and plasmids ................................................. 29 
`2.1.7  Commonly used buffer solutions, media and plates ............... 30 
`Basic molecular biology methods ....................................................... 31 
`2.2.1  Determination of oligonucleotide concentrations ................... 31 
`2.2.2  DNA preparation and cleaning up of nucleic acid
`solutions .............................................................................................. 31 
`2.2.3  Gel electrophoresis .................................................................. 33 
`2.2.4  Cloning of amplification products and transformation ........... 33 
`2.2.5  Polymerase chain reaction ....................................................... 35 
`Strand displacement amplification ...................................................... 36 
`2.3.1  Standard SDA .......................................................................... 36 
`2.3.2  Nicking SDA ........................................................................... 38 
`2.3.3  Elongation ............................................................................... 38 
`2.3.4  Experimental optimization ...................................................... 39 
`2.3.5  Optimization of template and primer design ........................... 39 
`2.3.6  Saturable inhibition through the use of additives .................... 40 
`
`2.2 
`
`2.3 
`
`3
`
`6
`
`

`

`4
`
`
`
`TABLE OF CONTENTS
`
`2.4 
`
`2.5 
`
`Characterization of molecular beacons ............................................... 42 
`2.4.1  Determination of the signal-to-background ratio .................... 42 
`2.4.2  Recording of the thermal denaturation profile ........................ 44 
`2.4.3  Construction of a phase diagram ............................................. 44 
`Selection-amplification cycle ............................................................. 47 
`Immobilization
`of DNA
`oligonucleotides
`on
`2.5.1 
`microparticles ...................................................................................... 47 
`2.5.2  Determination of the coupling efficiency ................................ 47 
`2.5.3  Experimental setup .................................................................. 48 
`2.5.4  Determination of the binding energy ...................................... 49 
`SDA in microstructures ...................................................................... 50 
`2.6.1  SDA module ............................................................................ 50 
`2.6.2  SDA in microfluidic structures: fan reactor ............................ 52 
`3  Results ............................................................................................................ 59 
`3.1 
`Strand displacement amplification ...................................................... 59 
`of
`the
`system
`and
`experimental
`3.1.1  Description
`optimization of the reaction conditions .............................................. 59 
`of
`an
`algorithm
`to
`optimize
`3.1.2  Development
`oligonucleotide design ........................................................................ 71 
`3.1.3  Saturable inhibition as a means of generating non-linear
`reaction kinetics .................................................................................. 72 
`3.2  Molecular beacon MB:A11 binding studies ....................................... 77 
`3.2.1  Hybridization kinetics and thermodynamics ........................... 79 
`3.2.2  Hybridization experiments in sequence pools ......................... 83 
`Selection-amplification cycle ............................................................. 89 
`3.3.1  Selection using one probe ....................................................... 90 
`3.3.2  Selection using two probes ...................................................... 93 
`SDA in microstructures .................................................................... 104 
`3.4.1  SDA module .......................................................................... 105 
`3.4.2  SDA in the fan reactor: Temporospatially resolved
`representation of the SDA reaction under flow conditions ............... 105 
`
`2.6 
`
`3.3 
`
`3.4 
`
`
`
`
`
`
`7
`
`

`

`TABLE OF CONTENTS 5
`
`
`4  Discussion ..................................................................................................... 111 
`4.1 
`SDA as a flexible replication tool ..................................................... 112 
`4.2 
`Selection using DNA hybridization .................................................. 113 
`4.3 
`SDA in microfluidic systems ............................................................ 115 
`4.4 
`Outlook ............................................................................................. 117 
`A  Sequence data for the 2-probe selection ........................................................ I 
`A.1  Round 4 ..................................................................................... I 
`A.2  Round 6 .................................................................................... II 
`A.3  Round 8 .................................................................................. IV 
`A.4  Round 10 ................................................................................ VI 
`A.5  Round 12 ............................................................................... VII 
`A.6  Round 14 ................................................................................ IX 
`A.7  Round 16 .................................................................................. X 
`B  Binding energies of the 2-probe selection ............................................... XIII 
`C  Algorithms ................................................................................................. XXI 
`C.1  Optimization of oligonucleotide design ........................................... XXI 
`C.2  Determination of binding energies ................................................ XXV 
`C.3 
`Characterization of the thermodynamics of MB:A11 .................... XXX 
`C.4  Model for the characterization of selection events ..................... XXXII 
`D  List of abbreviations ............................................................................. XXXV 
`E  Symbols used in formulas .................................................................. XXXVII 
`References .................................................................................................... XXXIX 
`
`
`
`
`
`
`
`
`
`
`8
`
`

`

`6
`
`
`
`
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`TABLE OF CONTENTS
`
`
`
`9
`
`

`

`
`
`List of figures
`
`Figure 1.1: Pictorial representation of “fitness landscapes” ............................................................ 18 
`
`Figure 1.2: Basic mechanism of SDA using exo- DNA polymerase and the restriction enzyme
`BsoBI. ................................................................................................................................................. 19 
`
`Figure 2.1: Cloning vector pCR2.1-TOPO ...................................................................................... 30 
`
`Figure 2.2: SDA oligonucleotide structure. ..................................................................................... 40 
`
`Figure 2.3: Use of the partition function to screen for possible non-specific hybridization and
`elongation reactions. .......................................................................................................................... 41 
`
`Figure 2.4: Phase transitions in solutions with molecular beacons. ................................................ 43 
`
`Figure 2.5: SDA module for the real-time detection of the SDA reaction in microstructures. ...... 51 
`
`Figure 2.6: Setup of the tandem optics used to observe reactions in microstructures. ................... 53 
`
`Figure 2.7: Tandem optic components ............................................................................................. 54 
`
`Figure 2.8: Sketch of the fan reactor used to perform SDA under flow conditions. ....................... 55 
`
`Figure 2.9: Microscope setup for the detection of the SDA reaction in the fan reactor under flow
`conditions. .......................................................................................................................................... 56 
`
`Figure 3.1: Standard and nicking SDA in relation to reaction temperature. ................................... 61 
`
`Figure 3.2: SDA in relation to magnesium ion concentration. ........................................................ 62 
`
`Figure 3.3: Enzyme series: Dependency of nicking SDA on the concentrations of exo- Bst
`polymerase and the restriction enzyme N.BstNBI. ........................................................................... 63 
`
`Figure 3.4: Real-time detection of SDA on tSDAI and fitting of measurements to exponential and
`logistic growth models ....................................................................................................................... 63 
`
`Figure 3.5: Asymmetric SDA. .......................................................................................................... 65 
`
`Figure 3.6: Analysis of the SDA reaction products at different template starting concentrations. 67 
`
`Figure 3.7: Elongation experiment to characterize side products due to primer-dimer formation. 68 
`
`Figure 3.8: Effect of additives (hp-DNA, heparin and polyC) on the SDA. ................................... 70 
`
`Figure 3.9: Primer dilution series. .................................................................................................... 71 
`
`Figure 3.10: Flowchart of the SDA optimization algorithm ............................................................ 73 
`
`Figure 3.11: Analysis of the SDA reaction products of the optimized oligo design with the target
`sequence tSDAmin5. .......................................................................................................................... 74 
`
`7
`
`10
`
`

`

`8
`
`LIST OF FIGURES
`
`Figure 3.12: Inhibition of the SDA reaction SDAI with TOTO-1 at a constant template
`concentration. ..................................................................................................................................... 75 
`
`Figure 3.13: Inhibition of the SDA reaction with TOTO-1 at different initial template
`concentrations .................................................................................................................................... 76 
`
`Figure 3.14: Inhibition of the SDA reaction with TOTO-1 at different dye concentrations in the
`SDA module ....................................................................................................................................... 77 
`
`Figure 3.15: Inhibition of the SDA with PNA oligonucleotides in relation to concentration of
`template tSDAI. .................................................................................................................................. 78 
`
`Figure 3.16: Effect of the PNA oligonucleotides during the course of the SDA reaction. ............. 79 
`
`Figure 3.17: Representation of the molecular beacon MB:A11. ..................................................... 80 
`
`Figure 3.18: Determination of the melting temperatures of target sequences with known base
`sequence using the partition function. ............................................................................................... 83 
`
`Figure 3.19: Denaturation profile of the molecular beacon MB:A11 in equilibrium with the
`complementary target sequence and in relation to the concentration of the target sequence. ......... 84 
`
`Figure 3.20: Determination of the thermodynamic parameters ....................................................... 85 
`
`Figure 3.21: Free energy of the three phases of a solution of the molecular beacon MB:A11 in
`equilibrium with the complementary sequence complA11. .............................................................. 86 
`
`Figure 3.22: Titration of target sequences with different mispairings with the molecular beacon
`MB:A11. ............................................................................................................................................. 87 
`
`Figure 3.23: Representation of the distribution of the melting temperatures of the sequence pool in
`relation to the number of mispairings. ............................................................................................... 88 
`
`Figure 3.24: Melting curve of the molecular beacon MB:A11 in the presence of different target
`sequences with mispairings. .............................................................................................................. 89 
`
`Figure 3.25: Comparison of the measured melting curve of the molecular beacon MB:A11 with
`the sequence pool Y=T/C=91/1 as a target sequence. ....................................................................... 90 
`
`Figure 3.26: Determination of the melting temperature from the partition function. ..................... 91 
`
`Figure 3.27: Comparison of the computed and experimentally determined melting points of the
`molecular beacon MB:A11 by hybridization with different target sequences. ................................ 93 
`
`Figure 3.28: Calibration series with pSDAw2(6.0) in order to quantify the hybridization capacity
`of micromer-M particles coupled with I1R(SDA)TIVTV-NH2. ...................................................... 95 
`
`Figure 3.29: Alignment of the sequenced products from the 1-probe selection after five (V1 - V9)
`and six (VI1 - VI10) rounds with tSDAII as the start pool ............................................................... 96 
`
`
`
`
`
`11
`
`

`

`LIST OF FIGURES 9
`
`Figure 3.30: Representation of the probe binding regions P1 and P2 on tSDAI. ........................... 98 
`
`Figure 3.31: Calibration series with V5-0rR6G and V4-1R6G for quantification of the
`hybridization capacity of M-PVA microparticles coupled to Im5-0r and Im4-1r. ........................... 99 
`
`Figure 3.32: Alignment of the sequenced selection products after 16 rounds for tSDAI. ............ 101 
`
`Figure 3.33: Alignment of the sequenced products of the serial transfer after five and eight rounds.
` .......................................................................................................................................................... 102 
`
`Figure 3.34: Alignment of the sequenced selection/amplification products after 16 rounds with
`amplification of the selection products using PCR instead of SDA. .............................................. 102 
`
`Figure 3.35: Alignment of the sequenced selection products after 16 rounds for tSDAII. ........... 104 
`
`Figure 3.36: Model to characterize the proportion of sequences with no deletion in relation to
`selective advantage. ......................................................................................................................... 105 
`
`Figure 3.37: Representation of the molecular beacons for characterization of the selection
`products. ........................................................................................................................................... 106 
`
`Figure 3.38: Use of the molecular beacons to observe changes in binding affinity in SELEX
`experiments. ..................................................................................................................................... 106 
`
`Figure 3.39: Characterization of the SDA reaction in the SDA module. ...................................... 108 
`
`Figure 3.40: Product control of the SDA reaction in the fan reactor. ............................................ 108 
`
`Figure 3.41: SDA in the fan reactor in relation to flow velocity. .................................................. 109 
`
`Figure 3.42: Detection of the SDA on tSDAI in real-time and fitting of the measurements to
`logistic and exponential growth models. ......................................................................................... 110 
`
`Figure A.1: Sequencing of the selection/amplification products after 4 rounds starting with the
`template tSDAI. ..................................................................................................................................... I 
`
`Figure A.2: Sequencing of the selection/amplification products after 4 rounds starting with the
`sequence pool tSDAII. ........................................................................................................................ II 
`
`Figure A.3: Sequencing of the selection/amplification products after 6 rounds starting with the
`template tSDAI. ................................................................................................................................... II 
`
`Figure A.4: Sequencing of the selection/amplification products after 6 rounds starting with the
`sequence pool tSDAII. ....................................................................................................................... III 
`
`Figure A.5: Sequencing of the selection/amplification products after 8 rounds starting with the
`template tSDAI. .................................................................................................................................. IV 
`
`Figure A.6: Sequencing of the selection/amplification products after 8 rounds starting with the
`sequence pool tSDAII. ........................................................................................................................ V 
`
`
`
`
`
`12
`
`

`

`10
`
`LIST OF FIGURES
`
`Figure A.7: Sequencing of the selection/amplification products after 10 rounds starting with the
`template tSDAI. .................................................................................................................................. VI 
`
`Figure A.8: Sequencing of the selection/amplification products after 10 rounds starting with the
`sequence pool tSDAII. ....................................................................................................................... VI 
`
`Figure A.9: Sequencing of the selection/amplification products after 12 rounds starting with the
`template tSDAI. ................................................................................................................................ VII 
`
`Figure A.10: Sequencing of the selection/amplification products after 12 rounds starting with the
`sequence pool tSDAII. .................................................................................................................... VIII 
`
`Figure A.11: Sequencing of the selection/amplification products after 14 rounds starting with the
`template tSDAI. .................................................................................................................................. IX 
`
`Figure A.12: Sequencing of the selection/amplification products after 14 rounds starting with the
`sequence pool tSDAII. ....................................................................................................................... IX 
`
`Figure A.13: Sequencing of the selection/amplification products after 16 rounds starting with the
`template tSDAI. ................................................................................................................................... X 
`
`Figure A.14: Sequencing of the selection/amplification products after 16 rounds starting with the
`sequence pool tSDAII. ....................................................................................................................... XI 
`
`Figure A.15: Sequencing of the selection/amplification products after 16 rounds starting with the
`template tSDAI or the sequence pool tSDAII, however, with amplification of the selection
`products after selection round 16 by PCR instead of SDA. ............................................................ XII 
`
`
`
`
`
`
`
`
`
`13
`
`

`

`
`
`List of tables
`
`Table 2.6: Real-time detection settings ............................................................................................ 37 
`
`Table 2.7: Enzymes used. ................................................................................................................. 39 
`
`Table 2.8: Pipetting scheme for SDA under flow conditions in the fan reactor. ............................. 56 
`
`Table 3.1: Comparison of the binding of amplification product to tSDAI after asymmetric and
`symmetric SDA and after heat-denaturation ..................................................................................... 64 
`
`Table 3.2: Oligo designs. .................................................................................................................. 66 
`
`Table 3.3: Sequenced DNA ladder products. ................................................................................... 69 
`
`Table 3.4: Oligonucleotide sequence of the molecular beacon MB:A11 and the used target
`sequences with different mispairings. ............................................................................................... 81 
`
`Table 3.5: Presentation of sequence pools using binomial distribution .......................................... 82 
`
`Table 3.6: Comparison of computed and measured melting temperatures of the molecular beacon
`using different target sequences ......................................................................................................... 92 
`
`Table 3.7: Determination of the hybridization capacity of the micromer-M particles coupled to the
`oligonucleotide I1R(SDA)TIVTV-NH2. ........................................................................................... 94 
`
`Table 3.8: Selection steps for the 1-probe selection ......................................................................... 95 
`
`Table 3.9: Description of the selected sequences from the 1-probe experiments after rounds V and
`VI. ....................................................................................................................................................... 97 
`
`Table 3.10: Determination of the hybridization capacity of M-PVA particles coupled to the
`oligonucleotide Im4-1r or Im5-0r. ..................................................................................................... 99 
`
`Table 3.11: Selection steps for the 2-probe selection ..................................................................... 100 
`
`Table B.1: Computation of the energy of binding to the probes P1 and P2 after the
`selection/amplification experiments with the start sequence tSDAI ............................................. XIII 
`
`Table B.2: Computation of the energy of binding to the probes P1 and P2 after the
`selection/amplification experiments with the start pool tSDAII .................................................... XVI 
`
`
`
`
`
`
`
`
`11
`
`14
`
`

`

`LIST OF TABLES
`LIST OF TABLES
`
`12
`12
`
`
`
`
`
`
`
`
`
`
`
`15
`
`15
`
`

`

`
`
`
`
`
`
`Chapter 1
`1 Introduction
`
`[1]
`
`[2]
`
`[3]
`
`[4]
`
`[5]
`
`The importance of evolution was first described by Charles Darwin in 1848 in his book “On the
`origin of species by natural selection” [27]. The success and efficiency of the Darwinian theory of
`evolution is based on the distinction between genotype and phenotype, where the former is subject
`to variation and the latter to selection.
`In population genetics, the dynamics of evolution are represented as a process in the genotype
`sequence space. To describe the phenotype, empirical parameters are used. Optimization is a
`process within the genotype sequence space. However, without taking the phenotype into
`consideration, the description of evolutionary processes remains incomplete.
`Evolutionary optimization in asexually reproducing populations follows the Darwinian theory of
`evolution and is determined by the interaction of two processes with opposite effects on genetic
`heterogeneity: on the one hand, mutations increase the diversity of the genotypes; on the other
`hand, the diversity of phenotypes is reduced through selection. At first glance, the uncoupling of
`the goal of a mutation from selection appears to be disadvantageous. An advantageous mutation
`does not occur more frequently because it has a better chance of being selected. Nevertheless, in
`nature, the genotype-phenotype dichotomy ensures the random walk on the fitness landscape and
`results in optimization.
`Genotype and phenotype are different “entities” and, with few exceptions, it is impossible to map
`changes in phenotypic characteristics to known changes in the DNA sequence of the genotype.
`Metabolism is too complex in order to be able to construe it from the DNA sequence.
`Different strategies have been followed to find sufficiently simple systems that will facilitate the
`study of evolutionary processes. Thus, LENSKI and co-workers performed experiments under
`
`
`
`
`13
`
`16
`
`

`

`14 CHAPTER 1. INTRODUCTION
`
`[6]
`
`[7]
`
`[8]
`
`controlled growth conditions with bacterial cultures in chemostats [66, 67]. However, bacteria are
`too complex in order to be able to interpret the progress of evolution experiments at a molecular
`level.
`The simplest case of an evolutionary process in vitro, the optimization of ribozymes (RNA
`molecules that exhibit a genotype (RNA structure) as well as phenotype (RNA structure)), has
`been described successfully. JOYCE and co-workers develop a system that enables the continuous
`characterization of such an evolutionary process [80]. The system combines newly acquired
`functionality with selection and amplification.
`
`1.1 Molecular evolution
`Biochemical reactions such as nucleic acid amplification permit the investigation of macro
`evolutionary processes on a “laboratory timescale”. At the end of the 1960s, SPIEGELMANN and
`co-workers first demonstrated biochemically controlled evolution using the bacteriophage Qβ
`replicase [84]. Here, RNA molecules could be replicated in a test tube and, after sufficient
`generations, evolutionary phenomena in the Darwinian sense, such as selection and evolutionary
`adaptation to the environment, could be observed. This proved that the principles of evolution are
`not confined to cellular life. Rather, molecules that are capable of replicating and mutating suffice.
`The in vitro evolution of the RNA molecules mirrored evolution at an accelerated rate.
`Experiments into the mechanisms of evolution with regard to chemical kinetics have been
`conducted by BIEBRICHER et al. [12].
`
`1.1.1 In vitro selection and SELEX
`Molecular evolution makes it possible to isolate nucleic acids with catalytic activity or specific
`binding properties. In vitro selection methods such as SELEX (systematic evolution of ligands by
`exponential amplification) use large populations of random sequences of RNA or DNA as starting
`material to select specific functional molecules [36, 56]. Since the isolation of the reverse
`transcriptase and the invention of the polymerase chain reaction in the 1990s, it has been possible
`to amplify almost any nucleic acid in vitro and to thus combine in vitro selection and directed
`evolution in order to search the sequence space for highly-specialized RNA sequences [36, 121].
`Ligands resulting from in vitro selection are described as aptamers. In general, aptamers are
`created according to the foll

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket